DSP Healthcare Fund - Regular - IDCW Payout
DSP Asset Managers Private Limited
₹25.52 (+0.44%)
NAV as of 9 Oct 2026
Minimum Investment: ₹100
Return
12.80% Returns for 1Y
Expense ratio & Others
- Net expense ratio
- 1.94%
- Exit load
- 0%
- Lock-in
- No
- Minimum investment
- ₹100
- Category
- Sector - Healthcare
Expense ratio is inclusive of GST. Returns may be taxed based on the fund type and your holding period — please read the scheme-related documents and consult a tax advisor. Figures are historical and do not guarantee future results.
Fund Returns Estimator
One-time investment
₹1,000
6 months
₹1,199
Invested ₹1,000
▲+19.88%1 year
₹1,128
Invested ₹1,000
▲+12.80%3 years
₹1,189
Invested ₹1,000
▲+18.89%5 years
₹1,131
Invested ₹1,000
▲+13.11%
Based on the fund’s historic trailing returns — a planning illustration, not a guarantee of future results.
Invest One-TimePlan it your way
The figures above are fixed to this fund’s past returns over set periods. Use a calculator to set your own amount, tenure and expected rate of return.
Risk level
Riskometer scale
- Low
- Low to Moderate
- Moderate
- Moderate to High
- High
- Very HighThis fund
Riskometer level assigned by the fund house as per SEBI norms. It can change as the scheme’s portfolio changes.
Fund benchmark
| Primary Index Name | BSE Healthcare PR INR |
|---|---|
| Secondary Index Name | BSE Healthcare PR INR |
| Index Name | BSE Healthcare TR INR |
| Weighting | 100% |
Returns
| 1Y | 3Y | 5Y | 10Y | |
|---|---|---|---|---|
| Fund returns (%) | +12.80% | +18.89% | +13.11% | — |
| Cumulative returns (%) | +12.80% | +68.05% | +85.16% | — |
Fund Manager
| Manager | Chirag Dagli |
|---|---|
| Role | Manager |
| Manager Tenure | 5.84 yrs |
About Fund
| Date of Incorporation | 30 Nov 2018 |
|---|---|
| Fund House | DSP Asset Managers Private Limited |
| Custodian | Citibank, N.A. |
| Registrar / Transfer Agent | DSP Asset Managers Private Limited |
| Address | Citibank,180 Water St |
Top Holdings
| Company | Weightage (%) |
|---|---|
| Ipca Laboratories Ltd | 8.74% |
| Sun Pharmaceuticals Industries Ltd | 7.95% |
| Sai Life Sciences Ltd | 7.45% |
| Cipla Ltd | 7.35% |
| Apollo Hospitals Enterprise Ltd | 6.47% |
| Gland Pharma Ltd | 5.98% |
| Divi's Laboratories Ltd | 4.15% |
| Alkem Laboratories Ltd | 4.08% |
| Cohance Lifesciences Ltd | 3.81% |
| Laurus Labs Ltd | 3.76% |
| Vijaya Diagnostic Centre Ltd | 3.46% |
| Alembic Pharmaceuticals Ltd | 3.28% |
Investment Strategy
The primary investment objective of the scheme is to seek to generate consistent returns by predominantly investing in equity and equity related securities of pharmaceutical and healthcare companies/entities.
Long term capital growth
Mutual fund investments are subject to market risks. Read all scheme-related documents carefully. The data shown is for information only and does not constitute investment advice.